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The etiopathogenesis of eosinophilic nasal polyps is yet to be explained. Eosinophils are key 
components in the inflammatory infiltrate and are related to the perpetuation of the inflammatory 
process in chronic rhinosinusitis with nasal polyps.
Objective: This paper aims to evaluate the in vitro action of mitomycin upon the apoptotic index 
of nasal polyps.
Materials and Methods: This is a self-paired prospective experimental study using biopsy fragments 
from 15 patients with eosinophilic nasal polyps. Biopsy fragments were divided into two groups. 
In the case group, the fragments were treated with 400 µg/ml of mitomycin for five minutes. The 
control group fragments were treated with culture medium. The pair of fragments contained in the 
two first compartments - control and case - were immediately sent to the histopathologist. The other 
pair of samples containing control and case fragments was incubated for 12 hours. The fragments 
were then taken to the histopathologist for testing. The apoptotic index was determined by the 
morphometry in hematoxylin and eosin staining and DNA fragmentation analysis (TUNEL reaction).
Results: The comparison between the two groups showed a statistically significant difference 
(p < 0,001) in the apoptotic index of the 12-hour incubated cultures.
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INTRODUCTION
Eosinophilic Nasosinusal Polyposis is a chronic 
inflammatory proliferative affection of the nasal mu-
cosa and paranasal sinuses. Eosinophilic Nasosinusal 
Polyposis triggers different degrees of obstruction of 
the upper respiratory tract and both atopic patients and 
the general population suffer from it1,2. Nasal polyposis is 
considered part of a subdivision of chronic rhinosinusitis 
since it appears impossible to clearly differentiate both 
conditions3.
It is usually bilateral and has higher incidence in 
the fourties affecting 2.7% of the population, the majority 
of cases being men (with a proportion rate of 2.2/1). It 
is associated with asthma, eosinophilic non-allergic rhini-
tis, aspirin intolerance, eosinophilic fungal sinusitis, and 
Churg-Strauss syndrome. The incidence rate of Eosinophi-
lic Nasosinusal Polyposis is similar in both atopic patients 
and the general population, and its occurrence rises with 
the concomitant of bronchial asthma4,5.
Although the mechanisms of Eosinophilic Nasosinu-
sal Polyposis development are yet to be fully understood, 
it is known that the inflammatory response is involved in 
its formation process. It is assumed that the nasal polyps 
could be the final stage of a complex inflammatory process 
which is the result of multiple etiologies. The eosinophils 
and the structural polyp cells produce cytokines that keep 
both the ongoing inflammatory process and the recruit-
ment of new eosinophils. Cytokines such as Interleukin-5 
(IL-5) and granulocyte-macrophage colony-stimulating 
factor (GM-CSF) prolong the life span of eosinophils and 
improve their presence in the polypoid tissue, thus lowe-
ring the apoptosis index of these cells6. The detection of 
the vascular endothelial growth factor in cases of chronic 
sinusitis with polyps was linked to the induction of cell 
proliferation and inhibition of apoptosis of the epithelial 
cells evaluates in such cases7.
The corticosteroids are the main therapeutic clinic 
option for the nasosinusal polyposis due to its role in di-
minishing the inflammatory processes. It was possible to 
show the action of the corticosteroids over the apoptotic 
index of the cells of the stroma inflammatory infiltrate 
from Eosinophilic Nasosinusal Polyposis8-10. The growth of 
the BAX gene expression (pro-apoptotic) in eosinophilic 
nasal polyps raised the apoptosis index induced by the 
treatment with glicocorticoids11.
The quest for other therapeutic options has led to 
the study of the effect of drugs that can act in the inflam-
matory process cells. The aim would be to interrupt the 
pathophysiologic process that promotes and perpetuates 
the relapse in the nasosinusal polyposis occurrence. 
Mitomycin-C is an antineoplastic and antibiotic drug 
extracted from Streptomyces caespitosus that has been 
used as an antiproliferative agent12. In otorhinolaryn-
gology the application in humans have focused mainly 
on the action of the drug in the reduction of sinechiae 
in endoscopic nasal surgery13 as well as in laryngeal 
surgery14. Both human and animal applications confirm 
the safety of topical use of mitomycin-C15. Works that in-
vestigate the action of mitomycin-C in eosinophilic nasal 
polyps are scarce. It was possible to show the action of 
in vivo and in vitro mitomycin-C in diminishing the levels 
of both interleukin-5 and also granulocyte-macrophage 
colony-stimulating factor (GM-CSF) in eosinophilic nasal 
polyps. These oligoproteins diminish the rate of apoptosis 
in eosinophilic nasal polyps and prolong the survival of 
eosinophils16-18.
The aim of this study is to evaluate the actions of 
in vitro mitomycin-C in the eosinophilic nasal polyp’s 
eosinophils through autopaired experimental study with 
evaluation of the apoptotic index.
MATERIALS AND METHODS
This study has been submitted to and approved by 
the Research Ethics Committee under ETIC 484/08. Fifteen 
samples of Eosinophilic Nasosinusal Polyposis patients 
with eosinophils infiltration equal or higher than 40%19-21 
were studied. The research did not consider patients with 
non-eosinophilic polyposis or Eosinophilic Nasosinusal 
Polyposis patients with ongoing infection processes or 
under corticosteroids or histamine antagonist over 30 days 
before the study was actually carried out. Patients with 
septal deformities or anatomic variations have also been 
excluded. The major symptoms displayed by the patients 
were: anosmia, hyposmia, nasal obstruction, and post-nasal 
drip. All patients were advised to seek surgery. At first the 
polyps were extracted through biopsy of the medium mea-
tus and put in 10% formol solution. The samples were then 
proceeded to histopathologic exams with hematoxylin and 
eosin staining so as to characterize eosinophilia. Following 
that, the included patients underwent another biopsy. The 
samples of this biopsy were put in a three-orifice plate, 
each containing 250µl of culture medium RPMI 1.64022. The 
fragments contained in the first orifice were immediately 
prepared for histopathology and hence denominated zero 
hour control (0h). The other orifices constituted the control 
group (12 hours) and experimental group (12 hours). A 
400 µg/ml dose of mitomycin-C was administered to the 
experimental group for five minutes23. After that, the cultu-
res were washed with RPMI culture medium. The control 
group underwent the same procedures, but with the use 
of only RPMI 1640 culture medium. Fragments of both 
groups (control and experiment) were incubated at 37° C 
(98° F) and 0.5% CO
2
 for 12 hours. After that period, they 
were submitted to histopathology exams24. The samples 
of 15 patients were subjected to routine histopathology 
preparation (hematoxylin and eosin stain) for evaluation 
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of the apoptotic index through morphometry. A random 
sub-sample (n = 6 patients) underwent the TUNEL reaction 
for evaluation of DNA fragmentation.
Analysis of the apoptotic index through histopathology
For the analysis of the apoptosis index through he-
matoxylin and eosin stain, each blade had their eosinophils 
count in immersion oil at 100X magnification and their 
apoptosis index calculated. The figure was calculated by 
dividing the sum of eosinophils in apoptosis by the global 
sum of counted eosinophils25.
For characterizing an eosinophil in apoptosis, seve-
ral aspects were taken into account, namely: anoikis (cell 
retraction with loss of adherence between the adjacent 
cells); cytoplasmic condensation; nuclear condensation 
(chromatin condensation, with possible compaction of 
chromatin against karyotheca, displaying “crescent” figu-
res); nuclear and cytoplasmic fragmentation and formation 
of apoptotic bodies (Figures 1 and 2)25-27. Microscopic 
review was performed by two different searchers.
Analysis of the apoptotic index through DNA fragmentation 
(TUNEL reaction)
The occurrence of apoptosis was evaluated through 
the observation of genomic DNA fragmentation through 
TUNEL reaction. The procedure was carried out with the 
use of a commercial in situ genoma fragmentation detection 
kit (Klenow FragEl DNA fragmentation. Detection Kit - In 
QIA21 Catalog; Calbiochem /Oncogene- internet address: 
http://calbiochem.com/). The proteinase K span was set to 
20 minutes. The endogenous peroxidase was deactivated 
with 3% hydrogen peroxide for 5 minutes. The blades were 
washed with PBS (Phosphate Buffer Saline) and immersed in 
an equilibrium buffer solution. The samples were covered 
with the TdT enzyme (terminal deoxynucleotidyl transfe-
rase) and deoxynucleotides (labeled and non-labeled) and 
incubated in humid atmosphere at 37°C (98°F) for 2 hours. 
Then, they were washed in TBS 1X and covered in stop 
buffer (EDTA 0.5 M, ph = 8) for 5 minutes. Once again were 
the blades washed in TBS 1X and covered in blocking buffer 
for 10 minutes. They were kept in peroxidase-conjugated 
streptavidin diluted in blocking buffer and incubated in 
a humidified chamber at 37°C (98°F) for 30 minutes. The 
blades were washed in TBS 1X again and kept in DAB 
(Diaminobenzidine) for 6 minutes, washed in distilled water, 
counter stained with hematoxylin, and mounted. Positive 
and negative controls were used in all reactions (Figures 
3 and 4). Eosinophil count was recorded by one searcher.
Figure 1. histopathology of eosinophilic nasosinusal polyp (control 
group) incubated for 12 hours. (H. and E. 1000x).
Figure 2. Histopathology of eosinophilic nasosinusal polyp treated with 
mitomycin C and incubated for 12 hours (H. and E. 1000x). It is possible 
to identify the compatible alterations with eosinophils apoptosis in most 
of the cells (yellow arrows).
Figure 3. Histopathology of eosinophilic nasosinusal polyp (control 
group) incubated for 12 hours. (TUNEL 400x)
The eosinophils count was done at 40X magnifica-
tion with the apoptosis index calculated. The apoptosis 
index was calculated by dividing the sum of eosinophils 
in apoptosis by the global sum of counted eosinophils.
Statistical analysis
The computer programs used for statistical analysis 
were Statistical Package for Social Science (SPSS), version 17.0 
(SPSS. Inc, Chicago, IL, USA) and The R Project for Statistical 
Computing (GNU General Public License); version 2.9.1.
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In the apoptotic index analysis through TUNEL 
reaction, 645 frames were captured and analyzed at 400x 
magnification. All patients displayed significant difference 
in the three experiments: 0h control group, 12h control 
group, and 12h experimental group (p < 0,001).The posi-
tive TUNEL reaction was highlighted for all groups. The 
nuclei of cells in apoptosis were clearly distinguished by 
their brownish color. It was also possible to notice positive 
TUNEL reaction in other inflammatory infiltrate cells of 
the eosinophilic nasal polyps. The individual result of the 
apoptotic index of the sub-samples of 6 patients in vitro 
can be evaluated in Figure 6.
Figure 4. Histopathology of eosinophilic nasosinusal polyp treated with 
mitomycin C and incubated for 12 hours (TUNEL 400x).
The results achieved were submitted to the Kol-
mogorov-Smirnoff and Shapiro-Wilk tests for verification 
of normality. The analyzed data were submitted to the 
Kruskall-Wallis test for comparison of apoptotic indexes, 
followed by the Wilcoxon post-test with Bonferroni cor-
rection. A significance level of 5% was considered.
RESULTS
1.214 frames were captured and analyzed in the 
apoptosis index evaluation through morphometry. The com-
parison between the 0h control, 12h control, and 12h expe-
rimental groups has shown significant difference between 
the three experiments (p < 0,001), as shown in Figure 5.
Figure 5. Analysis of apoptotic index through morphology (hematoxylin 
and eosin stain. 1000x magnification). Kruskall Wallis test: p < 0,001 for 
all patients. Wilcoxon post-test with Bonferroni correction: p < 0,001 
for all patients/comparisons, except for both zero marks in which 
p-value= 0.1724. “0” refers to zero hour incubation period; “12-” is 12 
hour incubation with no treatment whatsoever and “12+” is 12 hour 
incubation with Mitomycin-C.
Figure 6. Apoptotic index (n = 6 patients) evaluated through TUNEL 
reaction. Kruskall Wallis test: p < 0,001 for all patients. Mann-Whitney 
post-test with Bonferroni correction: p < 0,001 for all patients/com-
parisons.
DISCUSSION
Eosinophils are the main kind of cells related to the 
Eosinophilic Nasosinusal Polyposis physiopathology. It is 
known that they prolong the life span in the inflammatory 
infiltrate of Eosinophilic Nasosinusal Polyposis patients28. 
The removal of eosinophils from the polypoid tissue 
occurs through apoptosis29. The number of those cells in 
apoptosis in the inflammatory infiltrate in Eosinophilic 
Nasosinusal Polyposis patients is lower than that found in 
healthy tissues16. Eosinophils are able to produce a great 
amount of substance through which they can damage tis-
sues and perpetuate the inflammatory process30. Although 
the Eosinophilic Nasosinusal Polyposis physiopathology is 
yet to be fully understood, it is clear that the inflammatory 
response is involved in its formation process. Cytokines 
such as IL5 and GM-CSF prolong the eosinophils life 
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span and therefore their presence in the polypoid tissue, 
thus lowering the apoptosis level of these cells. These 
cytokines can be produced from an autocrine process. 
So the inhibition of the apoptosis process would slow 
the removal of eosinophils of the tissue, promoting in an 
indefinite manner the Eosinophilic Nasosinusal Polyposis 
inflammatory process6,26,31,32. Therefore, in this current 
study, there was a conscious choice for the evaluation of 
the apoptotic level of the eosinophils of the inflammatory 
infiltrate of Eosinophilic Nasosinusal Polyposis patients.
Mitomycin C has been used in preventing sinechiae 
and stenosis in endoscopic nasal surgery. The topic use 
of mitomycin-C is safe13. Studies on the substance as well 
as eosinophilic nasal polyps are scarce. The reduction 
of IL-5 and GM-CSF levels in eosinophilic nasal polyps 
in vitro suggests indirect mechanism of mitomycin-C in 
the eosinophilic nasal polyp’s eosinophils apoptosis17,18. 
In diminishing the expression of antiapoptotic proteins, 
Mitomycin-C would promote an imbalance between the 
proteins which regulate the apoptosis, thus resulting in 
the liberation of the apoptotic cascade.
In this study, mitomycin-C was the only variable in 
the manipulation of the control and experimental groups. 
On comparing the 12h control group and the 12h expe-
rimental group, it was noticeable that the growth of the 
apoptotic index in such groups can be partly explained by 
the cultures’ incubation period. The comparison between 
control and experimental in different incubation periods 
makes it possible to attribute the difference of the apoptotic 
index to the effect of mitomycin-C. Such results confirm 
the finding of specialized literature in what regards the 
actions of mitomycin-C in the inductionof the eosinophilic 
nasal polyp’s eosinophils apoptosis in vitro.
One of the aims of this study was to estimate the 
biologic event known as apoptosis. Two different metho-
ds were used: routine histopathology (hematoxylin and 
eosin stain) and immunohistochemical reaction (TUNEL 
reaction). It was possible to identify the compatible altera-
tions with the apoptosis evolution through morphometry: 
cytoplasmic condensation, nuclear condensation, loss of 
cellular contact, and formation of apoptotic bodies. The 
TUNEL reaction is a standard method for the evaluation 
of apoptosis. This method allows for highlighting the ge-
nomic DNA fragmentation that prematurely occurs in the 
apoptosis process. It’s a decisive stage of the process since 
from that point on it becomes irreversible. The formation 
of apoptotic bodies inhibits both the releasing of internal 
cellular constituents and the activation of the inflamma-
tory mediators. Apoptosis results in the resolution of the 
inflammatory process, quite differently from the necrotic 
process which allows for premature permeabilization of the 
cell membrane33. Since the estimative of a biologic event 
was one of the objectives of this study, the use of different 
methods makes it more reliable. This study lags compari-
son between Mitomycin -C treatment and Glucocorticoids 
treatment. Glucocorticoids have potent anti-inflamatory 
action and are the most common treatment for nasal 
polyps. It was shown the effect of glucocorticoidsover the 
apoptotic index of the cells of the stroma inflammatory 
infiltrate from Eosinophilic Nasosinusal Polyposis.
The expression of different proteins with antia-
poptotic action on the onset of Eosinophilic Nasosinusal 
Polyposis was shown in several studies; these only come 
to reaffirm the importance of the alteration in the apoptotic 
mechanisms in the nasal polyposis physiopathology34-37. 
One of these mechanisms of actions of mitomycin-C is 
likely to be the lowering of the interleukins (IL-5 and 
GM-CSF) with reduction of the expression of proapopto-
tic proteins17,32. So Mitomycin-C enhances the suspension 
of antiapoptotic mechanism, thus making it possible for 
the apoptotic index in eosinophilic nasal polyp’s eosino-
phils to grow. The eosinophils apoptosis can make for 
the resolution of the Eosinophilic Nasosinusal Polyposis 
inflammatory process. The analysis of samples though 
TUNEL reaction has also spotted fibroblasts, macrophages, 
and specially lymphocytes in the apoptotic process. The 
brownish color of these cells was more evident in the 12h 
experimental group. It is assumed that mitomycin-C also 
acts upon the other inflammatory infiltrate cells as well 
as upon the nasal polyp’s stroma. Further studies will be 
able to look into the action of mitomycin-C in the other 
eosinophilic nasal polyp’s cells.
Mitomycin-C represents a prospective option in the 
Eosinophilic Nasosinusal Polyposis treatment for the future 
and the study of its clinic administration allows for a more 
in-depth knowledge of the apoptotic tracts involved in 
the Eosinophilic Nasosinusal Polyposis physiopathology.
CONCLUSION
Therefore it is concluded that mitomycin-C acts in 
vitro upon eosinophilic nasal polyps hence inducting the 
growth of the apoptotic index of in vitro eosinophils. This 
study is in vitro and may not replicate what happens in 
vivo. Further studies will be necessary to study the action 
of mitomycin-C in eosinophilic nasal polyp in vivo.
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